ARDS presentation at ATS Conference 5/20 | ATHX Message Board Posts

Athersys, Inc.

  ATHX website

  •  Registered Members of Investor Village:
    Please make sure you are signed in to your Investor Village account to enjoy the full benefits of our service and avoid the MediaPass paywall. If the MediaPass offer page is blocking you, click the light blue "No thanks, take me back" link on the middle right side of the form to get to our home page where you can sign in by entering your Investor Village User Name and Password. 

     MediaPass subscribers: Please make sure you are logged in to your MediaPass subscription to bypass the paywall. You can do this by clicking the light blue "Already have a MediaPass account? Login here" link on the middle left side of the subscription offer form and then entering the email address and password you used when you first signed up with MediaPass.  

    For assistance call 888-222-7309 or email

ATHX   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1532 of 1962  at  5/14/2019 5:13:57 PM  by


ARDS presentation at ATS Conference 5/20

Dr Bellingan  presented at today's Investor Conference...

Dr. Geoff Bellingan is with the University College of London Hospitals. His bio from its website reads:

" Currently Medical Director for Surgery and Cancer board, covering critical care, anaesthesia, theatres, sterile services and medical physics in the Division. I was previously the clinical director for critical care. I am also Reader in Intensive Care Medicine at UCL and theme lead for the critical care and anaesthesia research theme for the Comprehensive Biomedical Research Centre. I am a chest physician who works clinically only in critical care."

Dr. Bellingan's "special interests are in Acute Respiratory Distress Syndrome (ARDS) and in sepsis and inflammation."


ATS Conference 2019

May 20, 2019
  • Dr. Geoff Bellingan, Medical Director at University College London Hospitals

Dr. Bellingan will present the data from the Athersys ARDS trial. His presentation is titled “Primary Analysis of a Phase 1/2 Study to Assess MultiStem® Cell Therapy, a Regenerative Advanced Therapy Medicinal Product (ATMP), in Acute Respiratory Distress Syndrome (MUST-ARDS)” Monday May 20, 2019 9:15 AM - 11:15 AM

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 153
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 All rights reserved. User Agreement
Financial Market Data provided by